SIPAI HEALTH (00314) Income Statement & Earnings

1.350
-0.050-3.57%

Market Closed May 15 16:07 CST

992.22MMarket Cap-7.22P/E (TTM)

SIPAI HEALTH (00314) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

Turnover

-54.64%2.07B

-48.22%1.22B

-3.11%4.57B

-3.04%2.36B

14.39%4.71B

29.15%2.44B

18.58%4.12B

21.78%1.89B

28.68%3.47B

--1.55B

Operating income

-54.64%2.07B

-48.22%1.22B

-3.11%4.57B

-3.04%2.36B

14.39%4.71B

29.15%2.44B

18.58%4.12B

21.78%1.89B

28.68%3.47B

1.55B

Cost of sales

57.89%-1.76B

50.91%-1.05B

2.76%-4.18B

3.83%-2.13B

-13.62%-4.3B

-29.76%-2.22B

-18.54%-3.78B

-19.50%-1.71B

-26.97%-3.19B

---1.43B

Operating expenses

57.89%-1.76B

50.91%-1.05B

2.76%-4.18B

3.83%-2.13B

-13.62%-4.3B

-29.76%-2.22B

-18.54%-3.78B

-19.50%-1.71B

-26.97%-3.19B

-1.43B

Gross profit

-19.44%311.33M

-23.08%176.1M

-6.82%386.43M

4.97%228.93M

22.93%414.7M

23.25%218.09M

19.02%337.35M

49.34%176.94M

51.69%283.45M

118.48M

Selling expenses

53.72%-128.83M

41.30%-80.89M

4.78%-278.35M

9.36%-137.82M

12.18%-292.32M

5.33%-152.05M

-14.20%-332.85M

-15.33%-160.61M

-58.88%-291.46M

---139.27M

Administrative expenses

17.92%-265.92M

7.02%-150.52M

6.85%-323.97M

7.69%-161.89M

39.52%-347.79M

30.50%-175.38M

14.18%-575.01M

19.01%-252.33M

-85.48%-670.02M

---311.54M

Research and development expenses

54.20%-10.2M

66.14%-5.08M

51.55%-22.26M

37.09%-15.01M

26.66%-45.95M

30.40%-23.86M

-5.82%-62.65M

-17.00%-34.29M

-29.43%-59.21M

---29.31M

Impairment and provision

72.63%-9.66M

21.51%-2.58M

-254.23%-35.3M

-79.93%-3.29M

-82.31%-9.97M

63.44%-1.83M

14.69%-5.47M

-81.60%-5M

-20.18%-6.41M

---2.76M

-Other impairment is provision

72.63%-9.66M

21.51%-2.58M

-254.23%-35.3M

-79.93%-3.29M

-82.31%-9.97M

63.44%-1.83M

14.69%-5.47M

-81.60%-5M

-20.18%-6.41M

---2.76M

Operating interest expense

----

13.66%-3.49M

----

-9.57%-4.04M

-4.10%-1.96M

-4.56%-3.69M

---1.88M

Special items of operating profit

72.14%-23.39M

-218.28%-18.48M

-312.20%-83.94M

-68.84%15.63M

-19.52%39.56M

181.42%50.16M

2.52%49.15M

-0.22%17.82M

65.38%47.95M

--17.86M

Operating profit

64.56%-126.67M

-10.91%-81.46M

-45.72%-357.39M

13.46%-73.45M

58.68%-245.25M

67.28%-84.87M

15.14%-593.51M

25.54%-259.42M

-82.40%-699.39M

-348.4M

Financing cost

53.44%-1.43M

45.39%-847K

---3.07M

14.97%-1.55M

----

---1.82M

----

Share of profits of associates

67.91%-60K

63.06%-58K

54.61%-187K

---157K

-224.47%-412K

----

141.61%331K

123.68%81K

310.77%137K

---342K

Special items of earning before tax

----

74.57%-775.26M

96.07%-85.1M

-363.75%-3.05B

---2.17B

Earning before tax

64.46%-128.16M

-9.59%-82.37M

-46.80%-360.64M

13.31%-75.16M

82.05%-245.67M

74.83%-86.7M

63.49%-1.37B

86.31%-344.44M

-260.06%-3.75B

-2.52B

Tax

215.70%1.38M

142.13%1.23M

-14.41%-1.19M

183.42%508K

68.66%-1.04M

60.61%-609K

-302.67%-3.32M

-4,168.42%-1.55M

30.03%-825K

--38K

After-tax profit from continuing operations

64.96%-126.78M

-8.69%-81.14M

-46.66%-361.83M

14.50%-74.65M

82.02%-246.71M

74.77%-87.31M

63.41%-1.37B

86.25%-345.99M

-259.73%-3.75B

-2.52B

Earning after tax

64.96%-126.78M

-8.69%-81.14M

-46.66%-361.83M

14.50%-74.65M

82.02%-246.71M

74.77%-87.31M

63.41%-1.37B

86.25%-345.99M

-259.73%-3.75B

-2.52B

Minority profit

93.41%-2.51M

-357.79%-9.15M

-520.44%-38.1M

-29.18%3.55M

860.15%9.06M

1,374.71%5.01M

85.19%-1.19M

105.07%340K

-1,170.21%-8.05M

---6.71M

Profit attributable to shareholders

61.61%-124.27M

7.95%-71.99M

-26.57%-323.74M

15.29%-78.2M

81.34%-255.77M

73.34%-92.32M

63.36%-1.37B

86.20%-346.33M

-258.70%-3.74B

-2.51B

Basic earnings per share

58.82%-0.21

0.00%-0.12

-27.50%-0.51

14.29%-0.12

96.72%-0.4

96.00%-0.14

67.59%-12.19

86.07%-3.5

-260.59%-37.61

-25.12

Diluted earnings per share

58.82%-0.21

0.00%-0.12

-27.50%-0.51

14.29%-0.12

96.72%-0.4

96.00%-0.14

67.59%-12.19

86.07%-3.5

-260.59%-37.61

-25.12

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021
Turnover	-54.64%2.07B	-48.22%1.22B	-3.11%4.57B	-3.04%2.36B	14.39%4.71B	29.15%2.44B	18.58%4.12B	21.78%1.89B	28.68%3.47B	--1.55B
Operating income	-54.64%2.07B	-48.22%1.22B	-3.11%4.57B	-3.04%2.36B	14.39%4.71B	29.15%2.44B	18.58%4.12B	21.78%1.89B	28.68%3.47B	1.55B
Cost of sales	57.89%-1.76B	50.91%-1.05B	2.76%-4.18B	3.83%-2.13B	-13.62%-4.3B	-29.76%-2.22B	-18.54%-3.78B	-19.50%-1.71B	-26.97%-3.19B	---1.43B
Operating expenses	57.89%-1.76B	50.91%-1.05B	2.76%-4.18B	3.83%-2.13B	-13.62%-4.3B	-29.76%-2.22B	-18.54%-3.78B	-19.50%-1.71B	-26.97%-3.19B	-1.43B
Gross profit	-19.44%311.33M	-23.08%176.1M	-6.82%386.43M	4.97%228.93M	22.93%414.7M	23.25%218.09M	19.02%337.35M	49.34%176.94M	51.69%283.45M	118.48M
Selling expenses	53.72%-128.83M	41.30%-80.89M	4.78%-278.35M	9.36%-137.82M	12.18%-292.32M	5.33%-152.05M	-14.20%-332.85M	-15.33%-160.61M	-58.88%-291.46M	---139.27M
Administrative expenses	17.92%-265.92M	7.02%-150.52M	6.85%-323.97M	7.69%-161.89M	39.52%-347.79M	30.50%-175.38M	14.18%-575.01M	19.01%-252.33M	-85.48%-670.02M	---311.54M
Research and development expenses	54.20%-10.2M	66.14%-5.08M	51.55%-22.26M	37.09%-15.01M	26.66%-45.95M	30.40%-23.86M	-5.82%-62.65M	-17.00%-34.29M	-29.43%-59.21M	---29.31M
Impairment and provision	72.63%-9.66M	21.51%-2.58M	-254.23%-35.3M	-79.93%-3.29M	-82.31%-9.97M	63.44%-1.83M	14.69%-5.47M	-81.60%-5M	-20.18%-6.41M	---2.76M
-Other impairment is provision	72.63%-9.66M	21.51%-2.58M	-254.23%-35.3M	-79.93%-3.29M	-82.31%-9.97M	63.44%-1.83M	14.69%-5.47M	-81.60%-5M	-20.18%-6.41M	---2.76M
Operating interest expense	----	----	----	----	13.66%-3.49M	----	-9.57%-4.04M	-4.10%-1.96M	-4.56%-3.69M	---1.88M
Special items of operating profit	72.14%-23.39M	-218.28%-18.48M	-312.20%-83.94M	-68.84%15.63M	-19.52%39.56M	181.42%50.16M	2.52%49.15M	-0.22%17.82M	65.38%47.95M	--17.86M
Operating profit	64.56%-126.67M	-10.91%-81.46M	-45.72%-357.39M	13.46%-73.45M	58.68%-245.25M	67.28%-84.87M	15.14%-593.51M	25.54%-259.42M	-82.40%-699.39M	-348.4M
Financing cost	53.44%-1.43M	45.39%-847K	---3.07M	14.97%-1.55M	----	---1.82M	----	----	----	----
Share of profits of associates	67.91%-60K	63.06%-58K	54.61%-187K	---157K	-224.47%-412K	----	141.61%331K	123.68%81K	310.77%137K	---342K
Special items of earning before tax	----	----	----	----	----	----	74.57%-775.26M	96.07%-85.1M	-363.75%-3.05B	---2.17B
Earning before tax	64.46%-128.16M	-9.59%-82.37M	-46.80%-360.64M	13.31%-75.16M	82.05%-245.67M	74.83%-86.7M	63.49%-1.37B	86.31%-344.44M	-260.06%-3.75B	-2.52B
Tax	215.70%1.38M	142.13%1.23M	-14.41%-1.19M	183.42%508K	68.66%-1.04M	60.61%-609K	-302.67%-3.32M	-4,168.42%-1.55M	30.03%-825K	--38K
After-tax profit from continuing operations	64.96%-126.78M	-8.69%-81.14M	-46.66%-361.83M	14.50%-74.65M	82.02%-246.71M	74.77%-87.31M	63.41%-1.37B	86.25%-345.99M	-259.73%-3.75B	-2.52B
Earning after tax	64.96%-126.78M	-8.69%-81.14M	-46.66%-361.83M	14.50%-74.65M	82.02%-246.71M	74.77%-87.31M	63.41%-1.37B	86.25%-345.99M	-259.73%-3.75B	-2.52B
Minority profit	93.41%-2.51M	-357.79%-9.15M	-520.44%-38.1M	-29.18%3.55M	860.15%9.06M	1,374.71%5.01M	85.19%-1.19M	105.07%340K	-1,170.21%-8.05M	---6.71M
Profit attributable to shareholders	61.61%-124.27M	7.95%-71.99M	-26.57%-323.74M	15.29%-78.2M	81.34%-255.77M	73.34%-92.32M	63.36%-1.37B	86.20%-346.33M	-258.70%-3.74B	-2.51B
Basic earnings per share	58.82%-0.21	0.00%-0.12	-27.50%-0.51	14.29%-0.12	96.72%-0.4	96.00%-0.14	67.59%-12.19	86.07%-3.5	-260.59%-37.61	-25.12
Diluted earnings per share	58.82%-0.21	0.00%-0.12	-27.50%-0.51	14.29%-0.12	96.72%-0.4	96.00%-0.14	67.59%-12.19	86.07%-3.5	-260.59%-37.61	-25.12
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--
Auditor	--	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"